BY BORIS SCHILLING WEISS
-
Employee representative leaves board of Novo Nordisk
Thomas Rantzau is leaving Novo Nordisk’s board as a staff member rep. He is changed by Tanja Villumsen, that is additionally the vice-chair of the union Pharmadanmark.
-
Eli Lilly plans to build a new factory in Pennsylvania for $3.5 billion
The brand-new manufacturing facility is planned to sustain the development of the business’s weight problems and diabetes mellitus therapies.
